PFE

9 New Stock Buybacks to Keep on Your Radar

Stock buybacks are considered a great sign for a company and for shareholders, but look through my picks here before you jump in with both feet More 

ACCL Stock – Accelrys Shares Skyrocket on Dassault Deal

France's Dassault says it will purchased Accelrys for $12.50 a share, sending ACCL stock jumping almost 29%. More 

Emerging Market Turmoil Gives Rally Frostbite

Emerging market turmoil and Apple stock's crash rule the headlines, but it's the ongoing earnings calendar that will eventually turn the stock market around. More 

Pfizer Stock Floats on Financial Engineering, Not Growth

Revenue is going nowhere, and Pfizer stock needs more than cost cuts and share buybacks to stop lagging both its peer group and the broader market. More 

Top 10 Dow Dividend Stocks for January

The market rally is getting more selective as we go deeper into 2014. Stick with these safe dividend stocks that have a history of dependable payouts. More 

MRK: Merck Stock a Strong Performer In the Pharma Space

Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More 

The S&P’s Most Dramatic Performances of 2013 (And What They Taught Us)

We look at 2013's best and worst performers in the S&P 500, as well as what that might say about returns in 2014. More